BACKGROUND: Crohn's disease (CD) patients with elevated granulocyte-macrophage colony-stimulating factor autoantibodies (GM-CSF Ab) are more likely to develop stricturing behavior requiring surgery. Computed tomography or magnetic resonance enterography (CTE or MRE) may detect luminal narrowing (LN) before stricture development. The objective of this study was to determine whether CD patients with elevated GM-CSF Ab (≥1.6 μg/mL) have a higher prevalence of LN and stricturing on CTE or MRE. METHODS: A single-center, cross-sectional study of 153 pediatric patients with CD and control subjects undergoing diagnostic CTE or MRE. Examinations were evaluated for disease activity using a novel scoring system and for the presence of LN, stricture, intra-abdominal abscess, or fistulae. Dichotomous outcomes were compared with respect to antibody status (high or low) using Fisher's exact test and logistic regression, whereas continuous outcomes were evaluated using unpaired t test. RESULTS: GM-CSF Ab were elevated in CD patients (n = 114) with a median (interquartile range) GM-CSF Ab level of 2.3 μg/mL (0.5-6.6 μg/mL) compared with 0.6 μg/mL (0.3-1.3 μg/mL) in healthy and disease control subjects (n = 39) (P = 0.001). Ileal disease location was more common in CD patients with high GM-CSF Ab (P < 0.001). LN increased from 39% in CD patients with low GM-CSF Ab to 71% in those with high levels (P = 0.004) and remained significantly associated with high GM-CSF Ab in a multivariate logistic model, which included age, gender, small bowel location, and duration of disease. Stricturing prevalence on CTE or MRE examination increased from 4% in CD patients with low GM-CSF Ab to 19% in those with high GM-CSF Ab (P = 0.03). CONCLUSIONS: Pediatric CD patients with high GM-CSF Ab levels have a higher prevalence of LN on CTE or MRE. Further study will be needed to determine whether medical therapy will reduce progression to stricturing behavior in these patients.
BACKGROUND:Crohn's disease (CD) patients with elevated granulocyte-macrophage colony-stimulating factor autoantibodies (GM-CSF Ab) are more likely to develop stricturing behavior requiring surgery. Computed tomography or magnetic resonance enterography (CTE or MRE) may detect luminal narrowing (LN) before stricture development. The objective of this study was to determine whether CDpatients with elevated GM-CSF Ab (≥1.6 μg/mL) have a higher prevalence of LN and stricturing on CTE or MRE. METHODS: A single-center, cross-sectional study of 153 pediatric patients with CD and control subjects undergoing diagnostic CTE or MRE. Examinations were evaluated for disease activity using a novel scoring system and for the presence of LN, stricture, intra-abdominal abscess, or fistulae. Dichotomous outcomes were compared with respect to antibody status (high or low) using Fisher's exact test and logistic regression, whereas continuous outcomes were evaluated using unpaired t test. RESULTS:GM-CSF Ab were elevated in CDpatients (n = 114) with a median (interquartile range) GM-CSF Ab level of 2.3 μg/mL (0.5-6.6 μg/mL) compared with 0.6 μg/mL (0.3-1.3 μg/mL) in healthy and disease control subjects (n = 39) (P = 0.001). Ileal disease location was more common in CDpatients with high GM-CSF Ab (P < 0.001). LN increased from 39% in CDpatients with low GM-CSF Ab to 71% in those with high levels (P = 0.004) and remained significantly associated with high GM-CSF Ab in a multivariate logistic model, which included age, gender, small bowel location, and duration of disease. Stricturing prevalence on CTE or MRE examination increased from 4% in CDpatients with low GM-CSF Ab to 19% in those with high GM-CSF Ab (P = 0.03). CONCLUSIONS: Pediatric CDpatients with high GM-CSF Ab levels have a higher prevalence of LN on CTE or MRE. Further study will be needed to determine whether medical therapy will reduce progression to stricturing behavior in these patients.
Authors: Karin Horsthuis; Lissy de Ridder; Anne M J B Smets; Maarten S van Leeuwen; Marc A Benninga; Roderick H J Houwen; Annemieke S Littooij; Rutger A J Nievelstein; Jaap Stoker Journal: J Pediatr Gastroenterol Nutr Date: 2010-11 Impact factor: 2.839
Authors: Cade M Nylund; Sharon D'Mello; Mi-Ok Kim; Erin Bonkowski; Jan Däbritz; Dirk Foell; Jon Meddings; Bruce C Trapnell; Lee A Denson Journal: J Pediatr Gastroenterol Nutr Date: 2011-05 Impact factor: 2.839
Authors: David H Bruining; Hassan A Siddiki; Joel G Fletcher; William J Sandborn; Jeff L Fidler; James E Huprich; Jayawant N Mandrekar; William S Harmsen; Paul E Evans; William A Faubion; Karen A Hanson; Steven B Ingle; Darrell S Pardi; Kenneth W Schroeder; William J Tremaine; Edward V Loftus Journal: Inflamm Bowel Dis Date: 2011-02-17 Impact factor: 5.325
Authors: Melvin B Heyman; Barbara S Kirschner; Benjamin D Gold; George Ferry; Robert Baldassano; Stanley A Cohen; Harland S Winter; Patricia Fain; Chris King; Terry Smith; Hashem B El-Serag Journal: J Pediatr Date: 2005-01 Impact factor: 4.406
Authors: Xiaonan Han; Kanji Uchida; Ingrid Jurickova; Diana Koch; Tara Willson; Charles Samson; Erin Bonkowski; Anna Trauernicht; Mi-Ok Kim; Gitit Tomer; Marla Dubinsky; Scott Plevy; Subra Kugathsan; Bruce C Trapnell; Lee A Denson Journal: Gastroenterology Date: 2008-12-24 Impact factor: 22.682
Authors: Kanji Uchida; David C Beck; Takashi Yamamoto; Pierre-Yves Berclaz; Shuichi Abe; Margaret K Staudt; Brenna C Carey; Marie-Dominique Filippi; Susan E Wert; Lee A Denson; Jonathan T Puchalski; Diane M Hauck; Bruce C Trapnell Journal: N Engl J Med Date: 2007-02-08 Impact factor: 91.245
Authors: Tomas Castro-Dopico; Aaron Fleming; Thomas W Dennison; John R Ferdinand; Katherine Harcourt; Benjamin J Stewart; Zaeem Cader; Zewen K Tuong; Chenzhi Jing; Laurence S C Lok; Rebeccah J Mathews; Anaïs Portet; Arthur Kaser; Simon Clare; Menna R Clatworthy Journal: Cell Rep Date: 2020-07-07 Impact factor: 9.423